Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > us compounding pharmacies market
Get a free sample of U.S. Compounding Pharmacies Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of U.S. Compounding Pharmacies Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Some of the key market players operating in the U.S. compounding pharmacies industry include:
among others. These market participants devise various strategies coupled with continuous innovations and product improvements to maintain competitive edge in the market.
The revenue of the U.S. non-sterile compounding pharmacies exceeded USD 3.5 billion in 2021 and will expand with the thriving need for modifying the route of administration based on patient convenience.
The 503B pharmacy type held close to 56.5% of the compounding pharmacies market share in the U.S. in 2021 and will grow owing to their ability to manufacture large batches of drugs for selling to healthcare facilities for office use.
The adult application segment accounted for close to 45.7% of the U.S. compounding pharmacies industry share in 2021 due to the rising prevalence of chronic diseases owing to sedentary lifestyles and food habits.
The compounding pharmacies industry size in the U.S. had crossed USD 5.2 billion in 2021 and is poised to record a 5.9% CAGR through 2030 due to the surging awareness and adoption of compounded medication in the region.